NPAIN FOCUS
Key issues around pharmacy, including pharmacy supervision and the effects of any potential changes to potential supervision regulations, were discussed at the recent Scottish NPA Forum. The event featured a policy discussion from a panel including NPA Director of Corporate and Public Affairs Gareth Jones, Matt Barclay (Community Pharmacy of Scotland Director of Operations), Siobhan McGuiness, Director for Scotland – General Pharmaceutical Council) and Right Medicine Pharmacy Director and Superintendent, Mike Embrey. There was consensus with the participating panel that with correct procedures, skill mix, delegation and accountability processes in place, changes could be made to pharmacy supervision without detriment to patient safety.
We would be delighted to meet Scottish members at the next NPA forum in March.
Naloxone service The Community pharmacy emergency supply of naloxone service commenced across Scottish pharmacies at the end of October. The NPA has developed a suite of resources to support members with the new service, including standard operating procedures, available at
www.npa.co.uk/services-and-support/nhs- services-scotland/
46
scottishpharmacist.com
Another recently published resource is the NPA Scottish Patient Safety Report October 23, which shares trends and learnings from reports submitted to the Scottish NPA patient safety reporting platform.
The recent report and the reporting platform are available to all pharmacy teams across Scotland at
www.npa.co.uk/services-and- support/patientsafety. Other new developments include a patient safety hub for valproate supply guidance and a clinical governance hub page for Scotland available on
www.npa.co.uk.
COVID-19 Public Inquiry The NPA has highlighted the ‘shocking’ and ‘disappointing’ exclusion of community pharmacists from benefits given to frontline healthcare staff during its latest evidence to Module 3 (Healthcare) of the UK COVID-19 public inquiry. Speaking at a recent hearing of the inquiry, which is examining all aspects of the UK Government’s handling of the pandemic, the NPA also again outlined the hugely significant ways community pharmacists helped protect vulnerable patients during the pandemic. Representing the NPA at the hearing, which was on Wednesday, September 27, Brian Stanton of Innovo Law, outlined how community pharmacists had been initially excluded by the
Janice Oman Scotland Representation Manager
Government from a life assurance scheme for healthcare workers who died during the course of their ‘essential and lifesaving work’. This decision was only reversed after strong joint petitions by the NPA, the Royal Pharmaceutical Society and others. The NPA has been approved as a ‘core participant‘ in Module 4 (vaccines) of the inquiry, which is considering various issues around the development of vaccines and vaccine rollout.
NPA Learning The NPA has an extensive range learning resources available to members and non- members. The NPA’s Learning and Development page includes access to the Learning Academy, training courses and programmes, information on Level 2 and 3 Pharmacy apprenticeships and much more. It also provides access to NPA Learn, where NPA members can login to their personalised learning records that contributes to the completion of CPD.
Visit
www.npa.co.uk/learning-and-development
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
